$RMD
RESMED INC

2022 Q2 Form 10-Q Financial Statement

#000094381922000006 Filed on April 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $914.7M $864.5M $894.9M
YoY Change 4.41% 12.45% 11.86%
Cost Of Revenue $392.2M $373.3M $390.6M
YoY Change 1.77% 16.11% 15.71%
Gross Profit $522.5M $491.2M $504.3M
YoY Change 6.48% 9.82% 9.05%
Gross Profit Margin 57.12% 56.82% 56.36%
Selling, General & Admin $194.9M $182.4M $185.4M
YoY Change 7.39% 13.68% 9.38%
% of Gross Profit 37.3% 37.13% 36.75%
Research & Development $64.32M $66.80M $62.51M
YoY Change 7.42% 19.41% 13.78%
% of Gross Profit 12.31% 13.6% 12.39%
Depreciation & Amortization $37.41M $42.31M $40.79M
YoY Change 1.78% 5.8% 0.52%
% of Gross Profit 7.16% 8.61% 8.09%
Operating Expenses $267.1M $256.9M $255.6M
YoY Change 7.25% 14.79% 6.16%
Operating Profit $255.4M $234.3M $248.7M
YoY Change 5.69% 4.85% 12.18%
Interest Expense -$19.78M $5.462M $5.948M
YoY Change 199.82% -6.2% 2.69%
% of Operating Profit -7.74% 2.33% 2.39%
Other Income/Expense, Net $2.468M -$7.946M -$11.43M
YoY Change -40.8% 46.58% 2.71%
Pretax Income $238.1M $226.3M $237.3M
YoY Change -0.47% 3.81% 12.68%
Income Tax $43.03M $47.31M $35.54M
% Of Pretax Income 18.07% 20.9% 14.98%
Net Earnings $195.1M $179.0M $201.8M
YoY Change -0.02% -328.1% 12.39%
Net Earnings / Revenue 21.32% 20.71% 22.55%
Basic Earnings Per Share $1.22 $1.38
Diluted Earnings Per Share $1.326M $1.22 $1.37
COMMON SHARES
Basic Shares Outstanding 146.3M shares 146.2M shares 146.0M
Diluted Shares Outstanding 147.0M shares 147.0M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $273.7M $201.8M $194.5M
YoY Change -7.3% -12.5% -24.0%
Cash & Equivalents $273.7M $201.8M $194.5M
Short-Term Investments
Other Short-Term Assets $131.3M $303.4M $209.9M
YoY Change 1.92% 41.82% 3.91%
Inventory $743.9M $664.9M $592.1M
Prepaid Expenses
Receivables $576.0M $508.6M $526.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.931B $1.704B $1.547B
YoY Change 22.65% 16.24% 6.6%
LONG-TERM ASSETS
Property, Plant & Equipment $498.2M $513.3M $477.8M
YoY Change 7.48% 12.78% 3.98%
Goodwill $1.936B $1.946B $1.951B
YoY Change 0.44% 1.06% 2.14%
Intangibles
YoY Change
Long-Term Investments $9.918M $12.48M $13.85M
YoY Change -42.18% -25.35% -36.1%
Other Assets $171.7M $169.4M $165.5M
YoY Change 6.73% 12.76% 5.11%
Total Long-Term Assets $3.164B $3.201B $3.188B
YoY Change 0.35% 2.61% 2.12%
TOTAL ASSETS
Total Short-Term Assets $1.931B $1.704B $1.547B
Total Long-Term Assets $3.164B $3.201B $3.188B
Total Assets $5.096B $4.905B $4.735B
YoY Change 7.78% 6.97% 3.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $159.2M $149.8M $163.4M
YoY Change 15.39% 27.79% 33.73%
Accrued Expenses $344.7M $326.3M $286.8M
YoY Change 7.52% 7.08% 2.31%
Deferred Revenue $108.7M $112.4M $111.6M
YoY Change -0.86% 6.75% 6.09%
Short-Term Debt $9.916M $11.97M $12.00M
YoY Change -17.37% -0.19% 0.1%
Long-Term Debt Due $9.916M $11.97M $12.00M
YoY Change -17.37% -0.28% 0.0%
Total Short-Term Liabilities $689.3M $667.3M $621.1M
YoY Change -24.4% -23.88% 7.57%
LONG-TERM LIABILITIES
Long-Term Debt $765.3M $668.7M $668.0M
YoY Change 18.96% -6.99% -17.91%
Other Long-Term Liabilities $5.974M $5.103M $6.350M
YoY Change -12.17% -15.89% -33.02%
Total Long-Term Liabilities $1.046B $959.2M $967.8M
YoY Change 12.37% -4.08% -14.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $689.3M $667.3M $621.1M
Total Long-Term Liabilities $1.046B $959.2M $967.8M
Total Liabilities $1.735B $1.626B $1.589B
YoY Change -5.83% -13.32% -6.97%
SHAREHOLDERS EQUITY
Retained Earnings $3.614B $3.480B $3.363B
YoY Change 17.34% 18.32% 9.3%
Common Stock $1.682B $1.645B $1.629B
YoY Change 3.71% 3.71% 3.48%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.623B $1.623B
YoY Change 0.0% 0.0%
Treasury Stock Shares 41.84M shares $41.84M
Shareholders Equity $3.361B $3.279B $3.146B
YoY Change
Total Liabilities & Shareholders Equity $5.096B $4.905B $4.735B
YoY Change 7.78% 6.97% 3.54%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income $195.1M $179.0M $201.8M
YoY Change -0.02% -328.1% 12.39%
Depreciation, Depletion And Amortization $37.41M $42.31M $40.79M
YoY Change 1.78% 5.8% 0.52%
Cash From Operating Activities $79.49M $117.4M $219.9M
YoY Change -64.91% -40.17% 29.42%
INVESTING ACTIVITIES
Capital Expenditures -$32.39M -$52.16M -$39.69M
YoY Change 5.09% 78.62% 4.18%
Acquisitions
YoY Change
Other Investing Activities -$22.85M $2.662M -$43.62M
YoY Change 32.55% -109.05% -619.25%
Cash From Investing Activities -$55.24M -$49.49M -$83.31M
YoY Change 14.94% -15.54% 180.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 57.50M -60.86M -218.0M
YoY Change -150.42% -61.6% -31.2%
NET CHANGE
Cash From Operating Activities 79.49M 117.4M 219.9M
Cash From Investing Activities -55.24M -49.49M -83.31M
Cash From Financing Activities 57.50M -60.86M -218.0M
Net Change In Cash 81.74M 7.086M -81.40M
YoY Change 26.88% -134.07% -53.91%
FREE CASH FLOW
Cash From Operating Activities $79.49M $117.4M $219.9M
Capital Expenditures -$32.39M -$52.16M -$39.69M
Free Cash Flow $111.9M $169.6M $259.6M
YoY Change -56.52% -24.79% 24.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000943819
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-15317
dei Entity Registrant Name
EntityRegistrantName
ResMed Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0152841
dei Entity Address Address Line1
EntityAddressAddressLine1
9001 Spectrum Center Blvd.
CY2022Q1 us-gaap Goodwill
Goodwill
1946317000 USD
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92123
dei Entity Address Country
EntityAddressCountry
US
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
836-5000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.004 per share
dei Trading Symbol
TradingSymbol
RMD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
146284655 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201769000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295278000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24411000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32138000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
508580000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
614292000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
664943000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
457033000 USD
CY2022Q1 us-gaap Prepaid Taxes
PrepaidTaxes
108898000 USD
CY2021Q2 us-gaap Prepaid Taxes
PrepaidTaxes
72409000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
220110000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
135745000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1704300000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1574757000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
513250000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
463490000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
141173000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
128575000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
1927901000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
355984000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
392582000 USD
CY2022Q1 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
74840000 USD
CY2021Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
79904000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
169400000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
160916000 USD
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3200964000 USD
CY2021Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
3153368000 USD
CY2022Q1 us-gaap Assets
Assets
4905264000 USD
CY2021Q2 us-gaap Assets
Assets
4728125000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
149797000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
138008000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
326276000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
320599000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24130000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23585000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
112449000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
109611000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
42646000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
307963000 USD
CY2022Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
11967000 USD
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
12000000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
667265000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
911766000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
94094000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
91496000 USD
CY2022Q1 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
10711000 USD
CY2021Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
11319000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
127254000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
114779000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5103000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6802000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
668735000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
643351000 USD
CY2022Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
53298000 USD
CY2021Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
62933000 USD
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
959195000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
930680000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1626460000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
1842446000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188102293 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
146266059 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
187484592 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
145648358 shares
CY2022Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
585000 USD
CY2021Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
583000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1645453000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1622199000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3480163000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3079640000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-224141000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-193487000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3278804000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2885679000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4905264000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
972319000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4728125000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
864500000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
768767000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2663390000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2320722000 USD
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
362321000 USD
CY2021Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
310585000 USD
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1128314000 USD
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
938253000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10982000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10924000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33271000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34066000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
373303000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
321509000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1161585000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
491197000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
447258000 USD
us-gaap Gross Profit
GrossProfit
1501805000 USD
us-gaap Gross Profit
GrossProfit
1348403000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
182401000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160446000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
544483000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
488904000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
66801000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55941000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
189258000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165409000 USD
CY2022Q1 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
7730000 USD
CY2021Q1 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
7445000 USD
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
23175000 USD
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
23377000 USD
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
8673000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
256932000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
223832000 USD
us-gaap Operating Expenses
OperatingExpenses
756916000 USD
us-gaap Operating Expenses
OperatingExpenses
686363000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
234265000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
223426000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
744889000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
662040000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
5462000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
5823000 USD
us-gaap Interest Expense
InterestExpense
16770000 USD
us-gaap Interest Expense
InterestExpense
18341000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2627000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4969000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5927000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9895000 USD
CY2022Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-1735000 USD
CY2021Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
4666000 USD
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-527000 USD
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
9442000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1878000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
705000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
729000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1205000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7946000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5421000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22495000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17589000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
226319000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
218005000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
722394000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
644451000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47307000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
296486000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138018000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
365046000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
179012000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-78481000 USD
us-gaap Net Income Loss
NetIncomeLoss
584376000 USD
us-gaap Net Income Loss
NetIncomeLoss
279405000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.22
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.92
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.91
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.26
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.17
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146240000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145513000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145969000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145217000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146962000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145513000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147034000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146394000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
179012000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-78481000 USD
us-gaap Net Income Loss
NetIncomeLoss
584376000 USD
us-gaap Net Income Loss
NetIncomeLoss
279405000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1046000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32822000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-30654000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
88009000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
177966000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-111303000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
553722000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
367414000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2885679000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4354000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-195000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17303000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23516000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
203613000 USD
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2021Q3 us-gaap Dividends
Dividends
61189000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3026049000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2378000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-49830000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
16723000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16101000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6092000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
201751000 USD
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2021Q4 us-gaap Dividends
Dividends
61245000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3145835000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2814000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2253000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15861000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1046000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
179012000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2022Q1 us-gaap Dividends
Dividends
61419000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3278804000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2497027000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1026000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
227000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16071000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
43791000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
178372000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2020Q3 us-gaap Dividends
Dividends
56511000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2678860000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1857000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-46732000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
15729000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15370000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
77040000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
179514000 USD
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2020Q4 us-gaap Dividends
Dividends
56654000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2864984000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
139000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3431000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15591000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-32822000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-78481000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2021Q1 us-gaap Dividends
Dividends
56752000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2709234000 USD
us-gaap Net Income Loss
NetIncomeLoss
584376000 USD
us-gaap Net Income Loss
NetIncomeLoss
279405000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
122198000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-650596000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4631000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
120034000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
26636000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
25805000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
49265000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
47032000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5927000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9895000 USD
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-527000 USD
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
9442000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
8673000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-98158000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39899000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
209476000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48393000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
127977000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
41036000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-277973000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
158119000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
271661000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
510193000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
106192000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74805000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17449000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11149000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
35915000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
30704000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
16614000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20038000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
6802000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
5309000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-26306000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-174677000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110390000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26269000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18759000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52278000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
49938000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3500000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
160000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
90000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
136000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
536000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
183853000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
169917000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-185862000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
18272000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-93509000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-232521000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295278000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
463156000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201769000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
230635000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
432268000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
180307000 USD
us-gaap Interest Paid Net
InterestPaidNet
16770000 USD
us-gaap Interest Paid Net
InterestPaidNet
18644000 USD
rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
8986000 USD
rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
15992000 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
2492000 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
3309000 USD
rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
33499000 USD
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
6598000 USD
rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
24202000 USD
rmd Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination
4078000 USD
rmd Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination
0 USD
rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
0 USD
rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
1681000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
35915000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
35204000 USD
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
5854000 USD
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
19797000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q1 rmd Lessor Lease Revenue
LessorLeaseRevenue
20743000 USD
CY2022Q1 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
946000 USD
CY2021Q1 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
2031000 USD
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
22746000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
69380000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
72551000 USD
CY2021Q1 rmd Lessor Lease Revenue
LessorLeaseRevenue
24777000 USD
rmd Lessor Lease Revenue
LessorLeaseRevenue
75978000 USD
rmd Lessor Lease Revenue
LessorLeaseRevenue
78405000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
864500000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
768767000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2663390000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2320722000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
155419000 USD
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4481000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4647000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
42306000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39988000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
122198000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
120034000 USD
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
340335000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
320127000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
296967000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
664943000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
457033000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1165391000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1085629000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
652141000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
622139000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
513250000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
463490000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
355984000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
392582000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
1927901000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
33499000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-15083000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
1946317000 USD
CY2022Q1 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
17842000 USD
CY2021Q2 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
29084000 USD
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
38180000 USD
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
23002000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
12477000 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
17154000 USD
CY2022Q1 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
68499000 USD
CY2021Q2 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
69240000 USD
CY2021Q2 rmd Equity Investments
EquityInvestments
69240000 USD
rmd Additional Equity Investments
AdditionalEquityInvestments
5713000 USD
rmd Observable Price Adjustments On Non Marketable Equity Securities
ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
5367000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-9666000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
3981000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
209000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5927000 USD
CY2022Q1 rmd Equity Investments
EquityInvestments
68499000 USD
CY2020Q2 rmd Equity Investments
EquityInvestments
44142000 USD
rmd Additional Equity Investments
AdditionalEquityInvestments
20038000 USD
rmd Observable Price Adjustments On Non Marketable Equity Securities
ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
1000000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
8442000 USD
rmd Reclassifications In Equity Investments
ReclassificationsInEquityInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9895000 USD
CY2021Q1 rmd Equity Investments
EquityInvestments
63727000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4500000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
4700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
9400000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-14100000 USD
us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
4100000 USD
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
22966000 USD
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
22032000 USD
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
21132000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
14653000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
11521000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
9689000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
11253000 USD
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
41000 USD
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
1566000 USD
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
27037000 USD
CY2022Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
11967000 USD
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
12000000 USD
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
670000000 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
646000000 USD
CY2022Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1265000 USD
CY2021Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2649000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
668735000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
643351000 USD
CY2022Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
680702000 USD
CY2021Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
655351000 USD
rmd Debt To Consolidated Ebitda Ratio
DebtToConsolidatedEbitdaRatio
3.50
rmd Line Of Credit Facility Collateral Percentage Of Company
LineOfCreditFacilityCollateralPercentageOfCompany
0.10
CY2022Q1 us-gaap Senior Notes
SeniorNotes
500000000 USD
CY2021Q2 us-gaap Senior Notes
SeniorNotes
500000000 USD
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
857799 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
179012000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-78481000 USD
us-gaap Net Income Loss
NetIncomeLoss
584376000 USD
us-gaap Net Income Loss
NetIncomeLoss
279405000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146240000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145513000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145969000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145217000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
722000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1065000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1177000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146962000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145513000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147034000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146394000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.22
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.92
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.91

Files In Submission

Name View Source Status
0000943819-22-000006-index-headers.html Edgar Link pending
0000943819-22-000006-index.html Edgar Link pending
0000943819-22-000006.txt Edgar Link pending
0000943819-22-000006-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
rmd-20220331.htm Edgar Link pending
rmd-20220331.xsd Edgar Link pending
rmd-20220331xex311.htm Edgar Link pending
rmd-20220331xex312.htm Edgar Link pending
rmd-20220331xex32.htm Edgar Link pending
rmd-20220331_cal.xml Edgar Link unprocessable
rmd-20220331_def.xml Edgar Link unprocessable
rmd-20220331_htm.xml Edgar Link completed
rmd-20220331_lab.xml Edgar Link unprocessable
rmd-20220331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending